Td Asset Management Inc Repare Therapeutics Inc. Transaction History

Td Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$12.5 - $18.13 $81,312 - $117,935	-6,505 Reduced 22.23%	22,758 $334,000
Q3 2022 Nov 07, 2022	SELL	$11.57 - $15.59 $62,998 - $84,887	-5,445 Reduced 15.69%	29,263 $352,000
Q2 2022 Aug 04, 2022	SELL	$8.45 - $14.84 $116,795 - $205,118	-13,822 Reduced 28.48%	34,708 $486,000
Q1 2022 May 10, 2022	SELL	$11.38 - $21.88 $219,611 - $422,240	-19,298 Reduced 28.45%	48,530 $691,000
Q4 2021 Feb 10, 2022	BUY	$19.66 - $28.11 $450,764 - $644,506	22,928 Added 51.06%	67,828 $1.43 Million
Q2 2021 Aug 11, 2021	BUY	$30.1 - $34.85 $1.35 Million - $1.56 Million	44,900 New	44,900 $1.5 Million

35.4M

50K

300

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $132M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.